OSUR stock forecast
Our latest prediction for OraSure Technologies, Inc.'s stock price was made on the May 14, 2019 when the stock price was at 8.74$.
In the short term (2weeks), OSUR's stock price should outperform the market by 2.75%. During that period the price should oscillate between -5.30% and +8.65%.
In the medium term (3months), OSUR's stock price should outperform the market by 3.34%. During that period the price should oscillate between -13.30% and +19.87%.Get email alerts
Create a solid portfolio with OSUR
About OraSure Technologies, Inc.
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
At the moment the company generates 170M USD in revenues.
On its last earning announcement, the company reported a profit of 0.31$ per share.
The book value per share is 4.33$
Three months stock forecastMay 14, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|